An update on the role of sex hormones in the function of the cardiorenal mitochondria

  • 0Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, U.S.A.

|

|

Summary

This summary is machine-generated.

Sex hormones influence mitochondrial energy production in the heart and kidneys. Understanding these sex differences in mitochondrial bioenergetics may reveal new therapeutic targets for cardiorenal diseases.

Area Of Science

  • Cardiorenal medicine
  • Mitochondrial bioenergetics
  • Endocrinology

Background

  • Mitochondrial dysfunction is key in cardiorenal diseases.
  • Premenopausal females show protection against cardiorenal pathology compared to males.
  • Sex hormones significantly impact cardiac and renal physiology.

Purpose Of The Study

  • To review recent evidence on sex hormones and mitochondrial bioenergetics in cardiorenal health and disease.
  • To highlight sex differences in mitochondrial metabolism and signaling.
  • To identify potential therapeutic targets for cardiorenal conditions.

Main Methods

  • Literature review focusing on data from the last 3-5 years.
  • Overview of mitochondrial function and sex hormones.
  • Focus on novel research linking sex hormones to mitochondrial pathways.

Main Results

  • Sex hormones bidirectionally regulate mitochondrial function.
  • Emerging evidence points to specific mitochondrial pathways influenced by sex hormones.
  • Significant gaps in knowledge exist regarding sex differences in mitochondrial bioenergetics.

Conclusions

  • Sex hormones play a critical role in cardiorenal mitochondrial energetics.
  • Further research into sex hormone-regulated mitochondrial pathways is warranted.
  • This knowledge can inform novel therapeutic strategies for cardiorenal diseases.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System 01:26

386

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Pathophysiology of Cardiac Performance 01:29

566

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...

Hormonal Regulation of Blood Pressure 01:17

2.5K

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...

Hormones of the Adrenal Glands 01:31

2.2K

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...

Pathophysiology of Heart Failure 01:17

1.5K

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Hormonal Regulation 01:33

33.0K

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.